Dr. med. Annic Weyersberg

Curriculum Vitae

 

Academic Background

01/2005

Doctorate in medicine

10/1994-11/2001

Medical degree from the University of Cologne

  
  

Professional Experience

since 10/2013

Research Associate at the Ethics Research Center at the Cologne University Hospital

10/2011-06/2012

Research Associate at the Cologne University Children’s Hospital in pediatric nephrology, immunology, and hypertensiology

07/2009-06/2010

Research Associate at the Cologne University Children’s Hospital in general pediatrics and neonatology

11/2005-05/2009

Expert in secondment and research associate with the European Medicines Agency (EMA), London, Great Britain

Main task: Preparation and implementation of the regulation on children’s medicaments

02/2005-10/2005

Research Associate of the pediatric network of the Cologne University Children’s Hospital’s coordination center for clinical studies

Main task: Counselling and coordination of pediatric studies

07/2002-01/2005

Resident and subsequently research associate at the Cologne University Children’s Hospital in the pediatric endocrinology, nephrology, and pneumatology-allergology unit  

  

Memberships

  • German Society for Pediatrics and Youth Medicine
  • Member of the Cologne University Hospital’s Ethics Commission (since 2008)
  • Board member of the Center for Clinical Studies of the University of Cologne (2009 – 2012)
  

Publications

Articles

Herold R, Weyersberg A, Saint Raymond A: „Better Medicines for Children“. In: Die Mitteilungen von GPOH und KPOH, eds Creutzig U, p4 doi:10.1591/poh.mitteilungen.20070601.1

Welzing L, Harnischmacher U, Weyersberg A, Roth B.:  Consequences of the Directive 2001/20/EC for Investigator Initiated Trials in the Paediatric Population – A field report. Eur J Pediatr. 2007 Nov;166(11):1169-76. Epub 2007 Feb 27

Licht C, Weyersberg A, Heinen S, Stapenhorst L, Devenge J, Beck B, Waldherr R, Kirschfink M, Zipfel PF, Hoppe B. Successful Plasma Therapy for Atypical Hemolytic Uremic Syndrome (aHUS) caused by Factor H Deficiency Owing to a Novel Mutation in the Complement Cofactor Protein Domain 15. Am J Kidney Dis. 2005Feb;45(2):415-421
 

Book contributions

Schönau, Naumann, Längler, Beuth: "Pädiatrie Integrativ – konventionelle und komplementäre Therapie“, Urban & Fischer, 2004
 

Lectures

Arzneimittel für Neugeborene – ein langer Weg – Symposium Forschung und Arzneimittelentwiclung für Neugeborene, Berlin – 04/2011

The EU Paediatric Regulation – Better Medicines for Children – Workshop: Tailormade Drug Treatment for Children, Leiden, Holland – 10/2007

The Paediatric Regulation – Lecture Department of Pharmacology & Trinity Centre for Health Sciences, St Jame’s Hospital, Dublin, Irland – 04/2007

Paediatric Medicines Information Leaflets – 35th European Symposium on Clinical Pharmacy, Wien, Österreich – 10/2006

Implementing the Paediatric Regulation – EMEA view – DIA Workshop on Pharma Legislation, Kopenhagen, Dänemark – 09/2006

European Union Legislation – Workshop: Addressing the Barriers to Pediatric Drug Development – The National Academies, Forum on Drug Discovery, Development and Translation, Washington, USA – 06/2006

Paediatric Medicines – The New European Legislation – Deutsche Gesellschaft für Regulatory Affairs, Bonn – 05/2006

Paediatric Regulation Principles – Faculté de Pharmacie de Châtenay-Malabry, Paris – 02/2006